美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Onestream Inc

23.85

-0.9400-3.79%

盤後：23.850.00000.00%19:52 EDT

成交量：101.62萬

成交額：2,465.78萬

市值：42.04億

市盈率：-13.50

高：25.00

開：24.95

低：23.76

收：24.79

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

AbbVie申請將Venclexta組合療法推進到CLL一線治療AbbVie files to move Venclexta combo into the CLL front line

Os Therapies Incorporated盤中異動大幅下跌6.01%

Os Therapies Incorporated盤中異動急速上漲5.03%報1.78美元

汽車汽配：6月乘用車零售銷量同比加速增長，國產品牌佔比達64.2%|興·研究

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":23.85,"timestamp":1753992000000,"preClose":24.79,"halted":0,"volume":1016233,"hourTrading":{"tag":"盘后","latestPrice":23.85,"preClose":23.85,"latestTime":"19:52 EDT","volume":12570,"amount":299774.59,"timestamp":1754005936709},"delay":0,"floatShares":69818472,"shares":176260091,"eps":-1.766751,"marketStatus":"未開盤","change":-0.94,"latestTime":"07-31 16:00:00 EDT","open":24.95,"high":25,"low":23.76,"amount":24657834.830213998,"amplitude":0.05002,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.766751,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":0,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":24.79,"preHourTrading":{"tag":"盘前","latestPrice":25,"preClose":24.79,"latestTime":"09:29 EDT","volume":215,"amount":5370.7,"timestamp":1753968599999},"postHourTrading":{"tag":"盘后","latestPrice":23.85,"preClose":23.85,"latestTime":"19:52 EDT","volume":12570,"amount":299774.59,"timestamp":1754005936709},"volumeRatio":1.082547,"impliedVol":0.7505,"impliedVolPercentile":0.836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","floatShares":69818472,"roa":"-35.83%","roe":"-108.78%","lyrEps":-1.232998,"volumeRatio":1.082547,"shares":176260091,"dividePrice":0,"high":25,"amplitude":0.05002,"preClose":24.79,"low":23.76,"week52Low":16.6942,"pbRate":"10.18","psRate":"8.16","week52High":35.39,"institutionHeld":0,"latestPrice":23.85,"eps":-1.766751,"divideRate":0,"volume":1016233,"delay":0,"ttmEps":-1.766751,"open":24.95,"prevYearClose":28.52,"prevWeekClose":25.01,"prevMonthClose":28.3,"prevQuarterClose":28.3,"fiveDayClose":25.05,"twentyDayClose":26.58,"sixtyDayClose":23.1,"earningDate":1754496000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555042530","title":"AbbVie申請將Venclexta組合療法推進到CLL一線治療AbbVie files to move Venclexta combo into the CLL front line","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042530","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555042530?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 21:18","pubTimestamp":1753881480,"startTime":"0","endTime":"0","summary":"AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia , in combination with an AstraZeneca drug.AbbVie已为其基于Venclexta疗法的方案申请批准，用于既往未经治疗的慢性淋巴细胞白血病患者，该方案与阿斯利康的一种药物联合使用。Calquence, meanwhile, is already approved for first-line CLL, but with a label that calls for treatment until disease progression, and approval based on the AMPLIFY data would allow patients to take a holiday from treatment, potentially reducing long-term side effects.Calquence 已经被批准用于一线 CLL 治疗，但其标签上要求持续治疗直到疾病进展，而基于 AMPLIFY 数据的批准将允许患者暂停治疗，这可能会减少长期副作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B4R5TH58.HKD","LU0738911758.USD","LU1093756168.USD","LU2347655156.SGD","LU2089284900.SGD","IE00B19Z3581.USD","LU1732799900.SGD","LU2237443465.HKD","BK4566","IE0004445239.USD","LU0943347566.SGD","BK4550","LU2237443382.USD","LU1244550577.SGD","AZ","LU0661504455.SGD","LU1267930573.SGD","LU1839511570.USD","LU2129689431.USD","LU1718418525.SGD","IE0009355771.USD","LU1037948897.HKD","LU1934455277.USD","LU0912757837.SGD","IE00BGHQF631.EUR","LU1989772840.SGD","OS","LU0158827948.USD","BK4581","LU0417517546.SGD","IE00BDGV0183.EUR","LU2237443549.SGD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU1983299246.USD","LU1037948541.HKD","LU1934455194.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU1732800096.USD","LU0456855351.SGD","LU1003077747.HKD","IE0002141913.USD","LU0234570918.USD","LU0256863902.USD","LU0985320562.USD","LU0820561818.USD","BK4533","LU1057294990.SGD","ABBV"],"gpt_icon":0},{"id":"2554782697","title":"Os Therapies Incorporated盤中異動 大幅下跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782697?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 00:56","pubTimestamp":1753376179,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日00时56分，Os Therapies Incorporated股票出现异动，股价大幅跳水6.01%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Plus Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Liminatus Pharma, Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Purple Biotech Ltd较为活跃，换手率分别为662.59%、365.70%、163.77%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Psyence Biomedical Ltd.，振幅分别为55.13%、50.00%、47.44%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OSTX","OS"],"gpt_icon":0},{"id":"2553706257","title":"Os Therapies Incorporated盤中異動 急速上漲5.03%報1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553706257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553706257?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 01:02","pubTimestamp":1753203734,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日01时02分，Os Therapies Incorporated股票出现异动，股价快速拉升5.03%。截至发稿，该股报1.78美元/股，成交量22.2009万股，换手率0.65%，振幅3.08%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.59%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OSTX","BK4139","OS"],"gpt_icon":0},{"id":"2553273694","title":"汽車汽配：6月乘用車零售銷量同比加速增長，國產品牌佔比達64.2%|興·研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2553273694","media":"华兴证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553273694?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 16:30","pubTimestamp":1753086650,"startTime":"0","endTime":"0","summary":"6月动力电池装车量同比增长36.0%至58.2GWh，单车平均带电量为54.0KWh，环比增长4.2%。6月国内乘用车厂商的零售/批发/生产数量均创当月历史新高，国产品牌零售市场份额达到64.2%。6月乘用车和新能源车零售销量同比分别增长18.1%/29.8%。2025年上半年累计总体乘用车和新能源车零售销量分别为1,094.8万辆/545.8万辆，分别同比增长11.2%/34.1%。6月乘用车销量数据创当月历史新高，国产品牌销量占比达64.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["82020","02020","ANPDY","BK4097","OS","BK4139","ADAG","ORR"],"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OS\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"OS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.01,"defaultRemindTime":1754596800000,"name":null,"time":"盤後","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"OS","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-02-11","symbol":"OS","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-11-07","symbol":"OS","fiscalQuarterEnding":"2024/09","expectedEps":0,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2024-09-03","symbol":"OS","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5714,"hold":0.0952,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1753329600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OS","date":"2025-07-30","current":-18.558189,"percent":0.833333,"low":-1655.61542,"twenty":-429.711933,"median":-25.973452,"eighty":-18.740999,"high":-14.493656,"avg":-323.068581,"sd":559.984,"marketCap":4365962454},"quantilePoints":[{"date":"2024-08-02","current":-402.058638,"twenty":-402.058638,"median":-402.058638,"eighty":-402.058638,"marketCap":4348264172},{"date":"2024-08-09","current":-394.529993,"twenty":-398.004752,"median":-394.602383,"eighty":-391.489578,"marketCap":4266841869},{"date":"2024-08-16","current":-420.156344,"twenty":-402.058638,"median":-395.977809,"eighty":-394.529993,"marketCap":4543990864},{"date":"2024-08-23","current":-418.563746,"twenty":-420.156344,"median":-400.248867,"eighty":-394.674774,"marketCap":4526766915},{"date":"2024-08-30","current":-439.701867,"twenty":-427.829772,"median":-415.668113,"eighty":-395.977809,"marketCap":4755375690},{"date":"2024-09-06","current":-1412.285699,"twenty":-434.093948,"median":-420.156344,"eighty":-395.977809,"marketCap":4652069092},{"date":"2024-09-13","current":-1421.532228,"twenty":-630.517125,"median":-426.381956,"eighty":-397.599363,"marketCap":4682527160},{"date":"2024-09-20","current":-1491.611188,"twenty":-1406.835113,"median":-428.55368,"eighty":-398.352228,"marketCap":4913367253},{"date":"2024-09-27","current":-1641.015636,"twenty":-1479.542034,"median":-435.672004,"eighty":-401.33473,"marketCap":5405505506},{"date":"2024-10-04","current":-1582.129844,"twenty":-1582.616503,"median":-445.348351,"eighty":-408.313205,"marketCap":5211535706},{"date":"2024-10-11","current":-1384.546111,"twenty":-1557.991535,"median":-1361.673117,"eighty":-414.50986,"marketCap":4560694889},{"date":"2024-10-18","current":-1422.505547,"twenty":-1506.405635,"median":-1387.466067,"eighty":-417.984619,"marketCap":4685733272},{"date":"2024-10-25","current":-1513.510863,"twenty":-1501.052381,"median":-1410.582391,"eighty":-419.837824,"marketCap":4985504782},{"date":"2024-10-31","current":-1488.204572,"twenty":-1545.825049,"median":-1419.58559,"eighty":-422.588676,"marketCap":4902145859},{"date":"2024-11-08","current":-29.444986,"twenty":-1544.267739,"median":-1421.532228,"eighty":-422.588676,"marketCap":5359016876},{"date":"2024-11-15","current":-29.547337,"twenty":-1525.190689,"median":-1414.232336,"eighty":-406.749563,"marketCap":5377644907},{"date":"2024-11-22","current":-27.361909,"twenty":-1504.167001,"median":-1405.472467,"eighty":-395.977809,"marketCap":4979894851},{"date":"2024-11-29","current":-26.339693,"twenty":-1496.769778,"median":-1384.546111,"eighty":-392.705744,"marketCap":4793850470},{"date":"2024-12-06","current":-28.33551,"twenty":-1493.655158,"median":-903.058146,"eighty":-29.829328,"marketCap":5157091209},{"date":"2024-12-13","current":-28.454992,"twenty":-1490.248542,"median":-439.701867,"eighty":-28.749622,"marketCap":5178836972},{"date":"2024-12-20","current":-27.223413,"twenty":-1484.895288,"median":-431.521704,"eighty":-28.258307,"marketCap":4954688343},{"date":"2024-12-27","current":-27.048786,"twenty":-1479.834029,"median":-428.191726,"eighty":-28.004145,"marketCap":4922906075},{"date":"2025-01-03","current":-25.973452,"twenty":-1479.444702,"median":-426.381956,"eighty":-27.732022,"marketCap":4727194212},{"date":"2025-01-10","current":-24.227183,"twenty":-1479.444702,"median":-422.183287,"eighty":-27.252823,"marketCap":4409371530},{"date":"2025-01-17","current":-26.460569,"twenty":-1468.54353,"median":-415.668113,"eighty":-26.869269,"marketCap":4815850013},{"date":"2025-01-24","current":-27.894348,"twenty":-1465.818237,"median":-402.058638,"eighty":-26.861301,"marketCap":5076799163},{"date":"2025-01-31","current":-27.407231,"twenty":-1462.314289,"median":-396.991281,"eighty":-26.925021,"marketCap":4988143362},{"date":"2025-02-07","current":-27.09474,"twenty":-1459.102337,"median":-394.674774,"eighty":-26.925021,"marketCap":4931269830},{"date":"2025-02-14","current":-19.646244,"twenty":-1457.642359,"median":-390.041762,"eighty":-26.782239,"marketCap":4247537655},{"date":"2025-02-21","current":-19.437413,"twenty":-1455.695721,"median":-30.305187,"eighty":-26.72172,"marketCap":4202388031},{"date":"2025-02-28","current":-18.385222,"twenty":-1452.094441,"median":-29.520901,"eighty":-26.562732,"marketCap":3974903390},{"date":"2025-03-07","current":-18.486889,"twenty":-1446.059864,"median":-28.777108,"eighty":-26.339693,"marketCap":3996883783},{"date":"2025-03-14","current":-16.449855,"twenty":-1440.122619,"median":-28.454992,"eighty":-26.179328,"marketCap":3556475076},{"date":"2025-03-21","current":-17.921046,"twenty":-1437.981318,"median":-28.198548,"eighty":-25.317223,"marketCap":3874548031},{"date":"2025-03-28","current":-18.76981,"twenty":-1430.38943,"median":-27.986257,"eighty":-24.094834,"marketCap":4058051659},{"date":"2025-04-04","current":-16.296269,"twenty":-1422.116219,"median":-27.889753,"eighty":-20.198845,"marketCap":3523269657},{"date":"2025-04-11","current":-15.87621,"twenty":-1419.974918,"median":-27.820821,"eighty":-19.520945,"marketCap":3432452458},{"date":"2025-04-17","current":-15.802935,"twenty":-1417.346957,"median":-27.682957,"eighty":-19.180725,"marketCap":3416610370},{"date":"2025-04-25","current":-17.317281,"twenty":-1415.400319,"median":-27.425612,"eighty":-18.846182,"marketCap":3744013527},{"date":"2025-05-02","current":-17.960471,"twenty":-1411.604376,"median":-27.370467,"eighty":-18.532156,"marketCap":3883071858},{"date":"2025-05-09","current":-18.233962,"twenty":-1408.19776,"median":-27.329108,"eighty":-18.405555,"marketCap":4289685457},{"date":"2025-05-16","current":-21.240398,"twenty":-1401.871187,"median":-27.223413,"eighty":-18.515128,"marketCap":4996973579},{"date":"2025-05-23","current":-21.307828,"twenty":-1386.882076,"median":-27.071763,"eighty":-18.645114,"marketCap":5012836988},{"date":"2025-05-30","current":-20.970679,"twenty":-1384.546111,"median":-26.979854,"eighty":-18.713226,"marketCap":4933519947},{"date":"2025-06-06","current":-21.779837,"twenty":-1366.053052,"median":-26.837395,"eighty":-18.714534,"marketCap":5123880845},{"date":"2025-06-13","current":-21.083062,"twenty":-1357.293182,"median":-26.745487,"eighty":-18.76981,"marketCap":4959958960},{"date":"2025-06-20","current":-21.397734,"twenty":-630.517125,"median":-26.722672,"eighty":-18.799724,"marketCap":5033988198},{"date":"2025-06-27","current":-20.715944,"twenty":-446.043303,"median":-26.635196,"eighty":-18.835877,"marketCap":4873591516},{"date":"2025-07-03","current":-19.974216,"twenty":-441.960461,"median":-26.551186,"eighty":-18.852455,"marketCap":4699094026},{"date":"2025-07-11","current":-19.329886,"twenty":-438.862005,"median":-26.400131,"eighty":-18.891318,"marketCap":4547510347},{"date":"2025-07-18","current":-18.603142,"twenty":-435.145985,"median":-26.322706,"eighty":-18.792246,"marketCap":4376538059},{"date":"2025-07-25","current":-18.767971,"twenty":-431.217662,"median":-26.184843,"eighty":-18.769074,"marketCap":4415315279},{"date":"2025-07-30","current":-18.558189,"twenty":-429.711933,"median":-25.973452,"eighty":-18.740999,"marketCap":4365962454}],"updateTime":1754002531318}}}